Having trouble accessing articles? Reset your cache.

Cilostazol-containing medicines regulatory update

EMA's CHMP recommended restricting the use of cilostazol-containing medicines to treat intermittent claudication for when lifestyle changes

Read the full 172 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE